Moderna shares tank after FDA delays COVID vaccine for 12- to 17-year-olds

Moderna shares tank after FDA delays COVID vaccine for 12- to 17-year-olds Shares in Moderna Inc. dropped at least 5% as trading opened Monday after a delay in the decision to approve the COVID-19 vaccine for adolescents ages 12-17. https://ift.tt/2ZQ9fMf https://ift.tt/3buZzJ9 Markets November 1, 2021 at 09:05PM